Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma-Reference-Cited by-同舟云学术

Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma

Published:2020-08 Issue:2 Volume:73 Page:285-293
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kusumoto Shigeru,Tanaka Yasuhito,Suzuki Ritsuro,Watanabe Takashi,Nakata Masanobu,Sakai Rika,Fukushima Noriyasu,Fukushima Takuya,Moriuchi Yukiyoshi,Itoh Kuniaki,Nosaka Kisato,Choi Ilseung,Sawa Masashi,Okamoto Rumiko,Tsujimura Hideki,Uchida Toshiki,Suzuki Sachiko,Okamoto Masataka,Takahashi Tsutomu,Sugiura Isamu,Onishi Yasushi,Kohri Mika,Yoshida Shinichiro,Kojima Minoru,Takahashi Hiroyuki,Tomita Akihiro,Atsuta Yoshiko,Maruyama Dai,Tanaka Eiji,Suzuki Takayo,Kinoshita Tomohiro,Ogura Michinori,Ueda Ryuzo,Mizokami Masashi

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab;Dervite;N Engl J Med,2001

2. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy;Hui;Gastroenterology,2006

3. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan;Umemura;Clin Infect Dis,2008

4. Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier;Fukushima;Ann Oncol,2009

5. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma;Kusumoto;Int J Hematol,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARCHITECT HBsAg Next assay is positioned better to resolve and refine challenging weak reactive clinical samples;Journal of Clinical Virology;2023-09

2. Adoptive immune transfer from donors offers Anti-HBV protection to HBsAb-negative patients after Allo-HSCT;iScience;2023-03

3. Noninvasive assessments of liver disease severity based on biomarkers;Comprehensive Guide to Hepatitis Advances;2023

4. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook;Nature Reviews Gastroenterology & Hepatology;2022-07-20

5. Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation;Journal of Gastroenterology;2022-04-28